Análisis de costes y resultados en la evaluación económica de las intervenciones sanitarias
Referencias bibliográficas (47)
- et al.
El establecimiento de prioridades
Aten Primaria
(2001) Introduction to health economics for physicians
Lancet
(2001)- et al.
La economía de la salud y su aplicación a la evaluación
Aten Primaria
(2001) - et al.
El análisis coste-beneficio en sanidad
Aten Primaria
(2001) - et al.
El análisis coste-efectividad en sanidad
Aten Primaria
(2001) - et al.
Análisis coste-utilidad
Aten Primaria
(2001) Clinical economics: a guide to the economic analysis of clinical practices
Jama
(1989)- et al.
Definitions of efficiency
Bmj
(1999) Economic evaluation and health care: the policy context?
Bmj
(1993)- et al.
Types of economic evaluation
Bmj
(1999)
Economic evaluation and health care: what does it mean?
Bmj
Measuring outcomes in economic evaluations
Bmj
Outcome measurement in economic evaluation
Health Economics
Output measures and valuation in health
Costing in economic evaluations
Assessing the costs of healthcare technologies in clinical trials
Health Technol Assess
The importance of indirect costs in primary cardiovascular disease prevention
Arch Intern Med
Opportunity Cost
Bmj
A practical guide for calculating indirect costs of disease
Pharmacoeconomics
How to calculate indirect costs in economic evaluations
Pharmacoeconomics
The measurement of indirect costs in the health economics evaluation literature: a review
Int J Technol Assess Health Care
Cited by (37)
[Translated article] Tuberculosis contacts tracing in Spain: Cost analysis
2022, Archivos de BronconeumologiaEconomic evaluation of complete revascularization versus stress echocardiography-guided revascularization in the STEACS with multivessel disease
2021, Revista Espanola de CardiologiaLumbar disc herniation surgery: Is it worth adding interspinous spacer or instrumented fusion with regard to disc excision alone?
2021, Journal of Clinical NeuroscienceCitation Excerpt :The clinical evidence about using an IS or fusion remains inconsistent and controversial, with low number of comparative studies, and therefore, no definitive conclusions can be made. In addition, accounting the consumption of economic resources for each intervention can be useful for the decision-making process [18–20]. The objective of our study was to analyze if adding IS or PLIF, offers clinical advantages in relation to microdiscetomy alone.
Tuberculosis contacts tracing in Spain: Cost analysis
2021, Archivos de BronconeumologiaEconomic impact of health resource optimisation in the approach to patients with hepatitis C
2019, Gastroenterologia y HepatologiaEconomic impact of rapid diagnostic methods in Clinical Microbiology: Price of the test or overall clinical impact
2017, Enfermedades Infecciosas y Microbiologia Clinica
- *
El Grupo ECOMED lo forman las siguientes personas: Fernando Antoñanzas, Xavier Badia, Erik Cobo, Fernando García Alonso, Juan del Llano, Vicente Ortún, José Luis Pinto, Luis Prieto, Joan Rovira, Carlos Rubio y José Antonio Sacristán (coordinador). Las opiniones de los autores no representan necesariamente las de los organismos en los que trabajan